Biotech and drug stocks
7.44k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop speciality drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three-month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called ‘Battling Cancer’.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| Biotech and drug stocks | +0.62% | - | - | - |
| ^GSPC | +1.02% | -2.83% | +23.33% | +5383.83% |
31 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 733.51 | +8.64 | +1.19% | 4:00 pm GMT-4 | 2.00M | 3.07M | 697.40B |
| NVO | Novo Nordisk A/S | 126.85 | +1.06 | +0.84% | 4:00 pm GMT-4 | 3.10M | 5.02M | 565.92B |
| JNJ | Johnson & Johnson | 146.14 | -0.68 | -0.46% | 4:00 pm GMT-4 | 6.17M | 7.66M | 352.17B |
| MRK | Merck & Co., Inc. | 131.2 | +0.48 | +0.37% | 4:00 pm GMT-4 | 6.25M | 8.44M | 332.33B |
| ABBV | AbbVie Inc. | 159.62 | -7.67 | -4.58% | 4:00 pm GMT-4 | 10.63M | 5.63M | 282.63B |
| AZN | AstraZeneca PLC | 75.17 | +0.14 | +0.19% | 4:00 pm GMT-4 | 6.19M | 6.38M | 233.06B |
| NVS | Novartis AG | 97.44 | -1.62 | -1.64% | 4:00 pm GMT-4 | 1.47M | 1.63M | 198.82B |
| RHHBY | Roche Holding AG | 30.25 | +0.23 | +0.77% | 4:00 pm GMT-4 | 2.82M | 2.68M | 194.31B |
| AMGN | Amgen Inc. | 269.98 | +0.60 | +0.22% | 4:00 pm GMT-4 | 2.44M | 2.96M | 144.81B |
| PFE | Pfizer Inc. | 25.4 | +0.14 | +0.55% | 4:01 pm GMT-4 | 36.70M | 42.22M | 143.83B |
| SNY | Sanofi | 49.13 | -0.23 | -0.47% | 4:00 pm GMT-4 | 4.14M | 2.02M | 122.65B |
| VRTX | Vertex Pharmaceuticals Incorporated | 397.48 | -0.22 | -0.06% | 4:00 pm GMT-4 | 677.78k | 1.20M | 102.73B |
| REGN | Regeneron Pharmaceuticals, Inc. | 883.2 | -7.48 | -0.84% | 4:00 pm GMT-4 | 502.94k | 466.46k | 96.94B |
| BMY | Bristol-Myers Squibb Company | 44.85 | +0.15 | +0.34% | 4:00 pm GMT-4 | 16.73M | 16.01M | 90.90B |
| GSK | GSK plc | 41.11 | +0.20 | +0.49% | 4:00 pm GMT-4 | 2.55M | 3.49M | 83.99B |
| GILD | Gilead Sciences, Inc. | 65.42 | +0.15 | +0.23% | 4:00 pm GMT-4 | 12.35M | 7.35M | 81.58B |
| ZTS | Zoetis Inc. | 158.42 | +5.06 | +3.30% | 4:00 pm GMT-4 | 4.21M | 3.44M | 72.39B |
| MRNA | Moderna, Inc. | 107.97 | +1.79 | +1.69% | 4:00 pm GMT-4 | 2.24M | 3.78M | 41.34B |
| TAK | Takeda Pharmaceutical Company Limited | 13.03 | -0.04 | -0.31% | 4:00 pm GMT-4 | 1.21M | 1.84M | 41.20B |
| HLN | Haleon plc | 8.45 | +0.05 | +0.60% | 4:00 pm GMT-4 | 2.89M | 5.70M | 38.58B |
| BIIB | Biogen Inc. | 208.9 | +6.44 | +3.18% | 4:00 pm GMT-4 | 1.89M | 1.26M | 30.42B |
| BAYRY | Bayer Aktiengesellschaft | 7.39 | +0.12 | +1.65% | 3:59 pm GMT-4 | 1.41M | 2.09M | 29.04B |
| ARGX | argenx SE | 372.8 | +4.20 | +1.14% | 4:00 pm GMT-4 | 228.78k | 289.82k | 22.51B |
| BNTX | BioNTech SE | 87.21 | +0.50 | +0.58% | 4:00 pm GMT-4 | 348.30k | 593.18k | 21.02B |
| GMAB | Genmab A/S | 28.15 | +0.69 | +2.51% | 4:00 pm GMT-4 | 339.61k | 559.35k | 18.27B |
| ALNY | Alnylam Pharmaceuticals, Inc. | 143.31 | -0.40 | -0.28% | 4:00 pm GMT-4 | 473.01k | 848.52k | 18.12B |
| ALPMY | Astellas Pharma Inc. | 9.55 | +0.01 | +0.10% | 3:59 pm GMT-4 | 451.95k | 324.31k | 17.12B |
| BGNE | BeiGene, Ltd. | 153.58 | +5.02 | +3.38% | 4:00 pm GMT-4 | 204.92k | 240.75k | 16.89B |
| RPRX | Royalty Pharma plc | 28 | -0.11 | -0.39% | 4:00 pm GMT-4 | 1.31M | 2.81M | 16.73B |
| TEVA | Teva Pharmaceutical Industries Limited | 13.81 | +0.56 | +4.23% | 4:00 pm GMT-4 | 10.28M | 10.10M | 15.64B |
- Yahoo Finance Video
Abbvie stock falls amid growing biosimilar competition
Pharmaceutical giant AbbVie Inc. (ABBV) shares came under pressure as the market closed on Friday, following the disappointing first quarter sales performance of the company's arthritis drug, Humira. The company forecast that Humira's sales could slow further in the face of heightened competition. Yahoo Finance's health reporter Anjalee Khemlani breaks down the details, providing insight into the rise of biosimilars in the market. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance. This post was written by Angel Smith
Investor's Business DailyA Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed
Stock market investors brace for a big week of earnings and econ as Apple, Amazon, Big Pharma and The Fed all line up to deliver news.
Investor's Business DailyDow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
